Inhibikase Therapeutics (IKT) Short term Debt (2022 - 2025)
Inhibikase Therapeutics (IKT) recorded Short term Debt of $37,944 in Q2 2025, down 75.1% from $152,224 a year earlier and down 49.3% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Short term Debt (2022 - 2025) Analysis & Trends
At the end of FY2024, Inhibikase Therapeutics reported Short term Debt of $110,517, down 26.4% from FY2023.
- Across earlier years, Short term Debt came in at $150,095 in FY2023 (+2.9%) and $145,836 in FY2022.
- The Q2 2025 figure is the lowest quarterly Short term Debt in data going back to Q3 2022.
- On a year-over-year basis, Short term Debt has declined for four consecutive quarters, with an average decline of 17.6% over the last eight quarters.
- Peak year-over-year performance for Short term Debt in the last five years was growth of 4.9% in Q3 2023, against a decline of 75.1% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $74,772 (Q1 2025), $110,517 (Q4 2024) and $145,210 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Inhibikase Therapeutics | 359.62 Mn | -225.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 37,944.00 |
| Mar 31, 2025 | 74,772.00 |
| Dec 31, 2024 | 110,517.00 |
| Sep 30, 2024 | 145,210.00 |
| Jun 30, 2024 | 152,224.00 |
| Mar 31, 2024 | 151,159.00 |
| Dec 31, 2023 | 150,095.00 |
| Sep 30, 2023 | 149,030.00 |
| Jun 30, 2023 | 147,966.00 |
| Mar 31, 2023 | 146,901.00 |
| Dec 31, 2022 | 145,836.00 |
| Sep 30, 2022 | 142,048.00 |
API Access
Inhibikase Therapeutics Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();